The Mechanism and Management of Adverse Cardiac Reactions Induced by Immune Checkpoint Inhibitors Therapy

Immune checkpoint inhibitors (ICIs) therapy has recently been introduced to all kinds of cancers. The adverse reactions associated with this therapy have attracted much attention. The heart-related adverse reactions are mainly the immune-related myocarditis and heart failure. Cases of adverse cardia...

Full description

Saved in:
Bibliographic Details
Main Authors: Fangning Rong, Kangting Ji, Yingpei Weng, Yangpei Peng
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Cardiology Research and Practice
Online Access:http://dx.doi.org/10.1155/2020/8367651
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849304342183542784
author Fangning Rong
Kangting Ji
Yingpei Weng
Yangpei Peng
author_facet Fangning Rong
Kangting Ji
Yingpei Weng
Yangpei Peng
author_sort Fangning Rong
collection DOAJ
description Immune checkpoint inhibitors (ICIs) therapy has recently been introduced to all kinds of cancers. The adverse reactions associated with this therapy have attracted much attention. The heart-related adverse reactions are mainly the immune-related myocarditis and heart failure. Cases of adverse cardiac reactions caused by ICIs therapy have been clearly reported. However, the pathogenesis of the adverse cardiac reactions remains unclear. Therefore, this article briefly reviews the mechanism and management of adverse cardiac reactions caused by ICIs therapy.
format Article
id doaj-art-10eb91be1966483987f5edeb94741c41
institution Kabale University
issn 2090-8016
2090-0597
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series Cardiology Research and Practice
spelling doaj-art-10eb91be1966483987f5edeb94741c412025-08-20T03:55:45ZengWileyCardiology Research and Practice2090-80162090-05972020-01-01202010.1155/2020/83676518367651The Mechanism and Management of Adverse Cardiac Reactions Induced by Immune Checkpoint Inhibitors TherapyFangning Rong0Kangting Ji1Yingpei Weng2Yangpei Peng3The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, ChinaThe Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, ChinaThe Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, ChinaThe Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, ChinaImmune checkpoint inhibitors (ICIs) therapy has recently been introduced to all kinds of cancers. The adverse reactions associated with this therapy have attracted much attention. The heart-related adverse reactions are mainly the immune-related myocarditis and heart failure. Cases of adverse cardiac reactions caused by ICIs therapy have been clearly reported. However, the pathogenesis of the adverse cardiac reactions remains unclear. Therefore, this article briefly reviews the mechanism and management of adverse cardiac reactions caused by ICIs therapy.http://dx.doi.org/10.1155/2020/8367651
spellingShingle Fangning Rong
Kangting Ji
Yingpei Weng
Yangpei Peng
The Mechanism and Management of Adverse Cardiac Reactions Induced by Immune Checkpoint Inhibitors Therapy
Cardiology Research and Practice
title The Mechanism and Management of Adverse Cardiac Reactions Induced by Immune Checkpoint Inhibitors Therapy
title_full The Mechanism and Management of Adverse Cardiac Reactions Induced by Immune Checkpoint Inhibitors Therapy
title_fullStr The Mechanism and Management of Adverse Cardiac Reactions Induced by Immune Checkpoint Inhibitors Therapy
title_full_unstemmed The Mechanism and Management of Adverse Cardiac Reactions Induced by Immune Checkpoint Inhibitors Therapy
title_short The Mechanism and Management of Adverse Cardiac Reactions Induced by Immune Checkpoint Inhibitors Therapy
title_sort mechanism and management of adverse cardiac reactions induced by immune checkpoint inhibitors therapy
url http://dx.doi.org/10.1155/2020/8367651
work_keys_str_mv AT fangningrong themechanismandmanagementofadversecardiacreactionsinducedbyimmunecheckpointinhibitorstherapy
AT kangtingji themechanismandmanagementofadversecardiacreactionsinducedbyimmunecheckpointinhibitorstherapy
AT yingpeiweng themechanismandmanagementofadversecardiacreactionsinducedbyimmunecheckpointinhibitorstherapy
AT yangpeipeng themechanismandmanagementofadversecardiacreactionsinducedbyimmunecheckpointinhibitorstherapy
AT fangningrong mechanismandmanagementofadversecardiacreactionsinducedbyimmunecheckpointinhibitorstherapy
AT kangtingji mechanismandmanagementofadversecardiacreactionsinducedbyimmunecheckpointinhibitorstherapy
AT yingpeiweng mechanismandmanagementofadversecardiacreactionsinducedbyimmunecheckpointinhibitorstherapy
AT yangpeipeng mechanismandmanagementofadversecardiacreactionsinducedbyimmunecheckpointinhibitorstherapy